Dhruvi Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.65 Cr
- Paid Up Capital ₹ 1.56 Cr
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 57.75 Cr
About Dhruvi Pharma
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TS2001PTC171830
- Company No.
039783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2001
- Date of AGM
01 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Dhruvi Pharma Private Limited offer?
Dhruvi Pharma Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Pharmaceutical Chemists, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anti Infective Drugs & Medicines, Remdesivir Injection.
Who are the key members and board of directors at Dhruvi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Shah  | Managing Director | 16-Jul-2001 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Venkat | Nominee Director | 09-Mar-2015 | Current |
| Deeptiben Shah | Director | 16-Jul-2001 | Current |
| Yashwant Singh | Nominee Director | 03-Jul-2018 | Current |
Financial Performance of Dhruvi Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dhruvi Pharma?
Unlock access to Dhruvi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Keimed Private LimitedArvind Venkat is a mutual person
Neelkanth Drugs Private LimitedArvind Venkat and Yashwant Singh are mutual person
Yashvi Distribution Services Private LimitedRupesh Shah and Deeptiben Shah are mutual person
- Yashvi Pharma Private Limited
Rupesh Shah and Deeptiben Shah are mutual person
Relicorp Logistics LlpRupesh Shah and Deeptiben Shah are mutual person
- Meditree Lifecare Llp
Rupesh Shah is a mutual person
Charges (Loans)
₹0
₹57.75 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 51.00 Cr
- Yes Bank Limited : 5.25 Cr
- 3I Infotech Trusteeship Services Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2016 | Hdfc Bank Limited | ₹1.00 Cr | Satisfied |
| 26 Feb 2015 | Hdfc Bank Limited | ₹50.00 Cr | Satisfied |
| 29 Sep 2011 | Yes Bank Limited | ₹5.25 Cr | Satisfied |
| 20 Nov 2007 | 3I Infotech Trusteeship Services Limited | ₹1.50 Cr | Satisfied |
How Many Employees Work at Dhruvi Pharma?
Unlock and access historical data on people associated with Dhruvi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhruvi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhruvi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.